pyridostigmine bromide has been researched along with scopolamine hydrobromide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Alhalel, A; Alkalay, M; Almog, S; Izraeli, S; Menahem, S; Ruach, M; Tochner, Z; Versano, D; Ziv, I | 1 |
| Grogan, WA | 1 |
| Eldefrawi, ME; Schleifer, LA | 1 |
| Beers, ET; Brennecke, LH; Sparenborg, S | 1 |
| Alhalel, A; Alkalay, M; Almog, S; Glovinsky, J; Izraeli, S; Ruach, M; Versano, D; Ziv, I | 1 |
| Alkalay, D; Chapman, S; Cohen, G; Gilat, E; Rabinovitz, I; Raveh, L; Weissman, BA | 1 |
| Hoffman, A; Perlstein, I | 1 |
| Baubichon, D; Carpentier, P; Dorandeu, F; Foquin, A; Lallement, G | 1 |
| Hall, T; Passingham, S; Wetherell, J | 1 |
| Koplovitz, I; Schulz, S | 1 |
| Joosen, MJ; Kuijpers, WC; Noort, D; van der Schans, MJ; van Helden, HP | 1 |
1 review(s) available for pyridostigmine bromide and scopolamine hydrobromide
| Article | Year |
|---|---|
Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Chemical Warfare Agents; Cholinesterase Inhibitors; Decontamination; Disease Models, Animal; Guinea Pigs; Organophosphate Poisoning; Organothiophosphorus Compounds; Procyclidine; Pyridostigmine Bromide; Scopolamine; Skin; Time Factors | 2013 |
2 trial(s) available for pyridostigmine bromide and scopolamine hydrobromide
| Article | Year |
|---|---|
Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine.
Topics: Acetylcholinesterase; Administration, Cutaneous; Adolescent; Adult; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Pyridostigmine Bromide; Salivation; Scopolamine; Tablets | 1992 |
Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine.
Topics: Adolescent; Adult; Antiemetics; Cholinesterase Inhibitors; Double-Blind Method; Humans; Male; Pyridostigmine Bromide; Scopolamine; Vision, Ocular | 1995 |
10 other study(ies) available for pyridostigmine bromide and scopolamine hydrobromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Treatment of myasthenia gravis with pyridostigmine.
Topics: Administration, Cutaneous; Adult; Female; Humans; Myasthenia Gravis; Pyridostigmine Bromide; Scopolamine | 1987 |
Identification of the nicotinic and muscarinic acetylcholine receptors in subcellular fractions of mouse brain.
Topics: Acetylcholine; Animals; Arecoline; Atropine; Brain; Bungarotoxins; Centrifugation, Density Gradient; Decamethonium Compounds; Dialysis; Gallamine Triethiodide; In Vitro Techniques; Iodine Radioisotopes; Membranes; Mice; Mitochondria; Nicotine; Pyridostigmine Bromide; Receptors, Adrenergic; Receptors, Cholinergic; Scopolamine; Subcellular Fractions; Sucrose; Synaptosomes; Tritium | 1974 |
Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman.
Topics: Analysis of Variance; Animals; Antidotes; Atropine; Brain; Cholinesterase Inhibitors; Diazepam; Electroencephalography; Guinea Pigs; Image Processing, Computer-Assisted; Male; Pralidoxime Compounds; Pyridostigmine Bromide; Scopolamine; Soman; Status Epilepticus | 1993 |
The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.
Topics: Animals; Brain; Cholinesterase Inhibitors; Cyclopentanes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Excitatory Amino Acid Antagonists; Flunitrazepam; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Parasympatholytics; Protein Binding; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Scopolamine; Seizures; Soman; Time Factors | 1999 |
Cumulative plot of heart rate variability spectrum assesses kinetics of action of cholinergic drugs in rats.
Topics: Animals; Atropine; Dose-Response Relationship, Drug; Heart Rate; Kinetics; Male; Muscarinic Antagonists; Parasympathetic Nervous System; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Regression Analysis; Scopolamine | 2000 |
Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
Topics: Alkaloids; Animals; Cholinesterase Inhibitors; Electroencephalography; Guinea Pigs; Male; Neuroprotective Agents; Physostigmine; Pyridostigmine Bromide; Scopolamine; Seizures; Sesquiterpenes; Soman; Time Factors | 2001 |
Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig.
Topics: Animals; Antidotes; Body Temperature; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterases; Drug Implants; Guinea Pigs; Male; Muscarinic Antagonists; Organothiophosphorus Compounds; Physostigmine; Pyridostigmine Bromide; Scopolamine; Weight Gain | 2002 |
Perspectives on the use of scopolamine as an adjunct treatment to enhance survival following organophosphorus nerve agent poisoning.
Topics: Animals; Atropine; Chemical Warfare Agents; Cholinergic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Guinea Pigs; Male; Military Medicine; Neurotoxicity Syndromes; Organophosphate Poisoning; Oximes; Pyridostigmine Bromide; Scopolamine; Survival Analysis | 2010 |